At the news
? NEUTRALIMPACT 3/10 SC 13G/A filed Nov 5, 2026 at 13:27 ET
FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 9,539,067 shares of Viking Therapeutics common stock as of September 30, 2026, representing 7.7% of shares outstanding. This is an increase from the prior filing by Vanguard Capital Management LLC, which reported 2,692,339 shares (5.0%) as of April 30, 2026. The filing is a routine passive stake update by a major institutional investor.
- FMR LLC (Fidelity) reported beneficial ownership of 9,539,067 shares of Viking Therapeutics common stock as of September 30, 2026
- The stake represents 7.7% of shares outstanding
- This is an amendment to Schedule 13G, indicating a passive investment intent
- The prior filing by Vanguard Capital Management LLC reported 2,692,339 shares (5.0%) as of April 30, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access